Principal Investigator: Michael Benatar, MD, PhD
This prospective study is designed to investigate the early manifestations of disease in people with recently diagnosed ALS (either familial or sporadic). We accomplish this by studying the unaffected regions of people with ALS. In addition to understanding the earliest phases of the disease, we aim to identify biomarkers of pre-symptomatic ALS.
Eligible study participants:
- Individuals affected with ALS (sporadic or familial)
- Healthy controls
All participants are recruited primarily from the Miami area and undergo 5 study visits, 1 every 3 months, at the University of Miami. A number of study procedures are performed at each visit, including the collection of biological samples, MRI, physiological and cognitive testing, and motor tasks and a neurological examination. Participants are remunerated $100 per completed study visit.
Back to Research Studies
